Amgen wins EU approval for Imdylltra in small cell lung cancer
Source: SeekingAlpha
2026-06-02 13:29:41 ET
More on Amgen
- Amgen's Growth Engine Is Just Getting Started
- Amgen Inc. (AMGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- Amgen Inc. (AMGN) Q1 2026 Earnings Call Transcript
- Amgen announces CFO transition
- Amgen’s Tavneos reportedly linked to 20 deaths in Japan
Read the full article on Seeking Alpha
For further details see:
Amgen wins EU approval for Imdylltra in small cell lung cancer
Amgen Inc.
NASDAQ: AMGN
AMGN Trading
3.31% G/L:
$356.085 Last:
1,232,839 Volume:
$348.76 Open:
AMGN Latest News
June 04, 2026 04:01:00 pm
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
June 03, 2026 09:00:00 am
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
AMGN Stock Data
$198,734,368,843
533,095,864
0.02%
1871
N/A
Pharmaceuticals
Healthcare
US
Thousand Oaks
